Sampleinformation
| ID . | Status* . | Time point (month/day/year) . | Proviral load (%) . | WBC, ×109/L . | Lymphocyte count (%) . | Abnormal lymphocyte (flower cell) count (%) . | Soluble interleukin-2 receptor, U/mL . |
|---|---|---|---|---|---|---|---|
| P1-1 | Asymptomatic carrier | 1/8/2008 | 1.1 | 6.00 | 37 | 3 | 307 |
| P1-2 | Asymptomatic carrier | 4/17/2013 | 1.24 | 5.80 | 12 | 5 | 4 790 |
| P2-1 | Asymptomatic carrier | 6/25/2010 | 5.24 | 3.40 | 48 | 0.5 | 232 |
| P2-2 | Asymptomatic carrier | 3/26/2013 | 1.23 | 3.69 | 40 | 2.3 | 435 |
| P3-1 | Asymptomatic carrier | 12/14/2007 | 1.15 | 5.18 | 32.5 | 2 | 435 |
| P3-2 | Asymptomatic carrier | 1/28/2010 | 3.68 | 5.56 | 37 | 0 | 373 |
| P4-1 | Asymptomatic carrier | 10/21/2009 | 3.52 | 9.40 | 29 | 1 | 504 |
| P4-2 | Asymptomatic carrier | 6/24/2013 | 8.73 | 7.40 | 22 | 0 | 291 |
| P5-1 | Asymptomatic carrier | 12/1/2011 | 7.16 | 6.48 | 34.5 | 4.5 | 453 |
| P5-2 | Asymptomatic carrier | 12/10/2013 | 12.76 | 5.37 | 36 | 2.3 | 292 |
| P6-1 | Asymptomatic carrier | 9/14/2007 | 11.82 | 6.32 | 35.5 | 2.5 | 325 |
| P6-2 | Smoldering | 10/11/2011 | 11.51 | 5.88 | 36 | 7 | 355 |
| P6-3 | Smoldering | 4/1/2014 | 15.41 | 5.66 | 33.5 | 7 | 300 |
| P6-4 | Smoldering | 3/30/2015 | 23.45 | 6.06 | 37.5 | 6.5 | 268 |
| P7-1 | Asymptomatic carrier | 9/7/2005 | 18.22 | 8.48 | 41 | 0 | 595 |
| P7-2 | Asymptomatic carrier | 9/6/2007 | 11.66 | 9.48 | 37.5 | 3.5 | 544 |
| P7-3 | Chronic | 5/2/2011 | 56.79 | 10.14 | 14.5 | 52 | 6 800 |
| P7-4 | Acute | 11/21/2011 | 98.31 | 27.23 | 8.4 | 65.4 | 10 700 |
| P8-1 | Asymptomatic carrier | 4/13/2011 | 13.41 | 4.30 | 39 | 3 | 626 |
| P8-2 | Smoldering | 6/20/2012 | 17.54 | 5.00 | 33 | 13 | 467 |
| P8-3 | Smoldering | 5/28/2014 | 45.27 | NA | NA | NA | NA |
| P8-4 | Chronic | 8/19/2015 | 41.02 | NA | NA | NA | NA |
| P9-1 | Asymptomatic carrier | 2/27/2012 | 19.82 | NA | NA | NA | NA |
| P9-2 | Smoldering | 5/1/2014 | 21.78 | NA | NA | NA | NA |
| P9-3 | Smoldering | 5/1/2015 | 43.85 | NA | NA | NA | NA |
| P10-1 | Smoldering | 9/6/2011 | 20.46 | 5.10 | 37 | 6 | 523 |
| P10-2 | Smoldering | 5/12/2015 | 40.67 | 6.20 | 34 | 6 | 643 |
| P11-1 | Smoldering | 10/4/2012 | 36.63 | 6.04 | 28.5 | 24.5 | 1 700 |
| P11-2 | Chronic | 7/18/2013 | 37.32 | 6.92 | 13.5 | 51 | 7 000 |
| P12-1 | Smoldering | 7/27/2009 | 23.56 | 5.00 | 23 | 18 | 992 |
| P12-2 | Chronic | 6/1/2013 | 65.78 | NA | NA | NA | NA |
| P13-1 | Smoldering | 9/29/2010 | 31.1 | 10.20 | 21 | 15 | 1 320 |
| P13-2 | Chronic | 7/26/2012 | 32.15 | 9.40 | 51 | 14 | 1 780 |
| P14-1 | Smoldering | 11/10/2009 | 55.12 | 14.00 | 7 | 52 | 1 940 |
| P14-2 | Chronic | 5/23/2013 | 54.39 | 11.80 | 16 | 35 | 2 260 |
| P15-1 | Smoldering | 5/11/2007 | 16.9 | 9.80 | 44 | 0 | 833 |
| P15-2 | Chronic | 11/10/2010 | 28.53 | 12.70 | 52 | 14 | 823 |
| P16-1 | Smoldering | 10/17/2002 | 44.80 | 7.40 | 15 | 32 | 1 250 |
| P16-2 | Acute | 5/20/2004 | 105.98 | 12.80 | 4 | 76 | 12 800 |
| P17-1 | Chronic | 12/15/2010 | 59.3 | NA | NA | NA | 1 700 |
| P17-2 | Chronic | 11/26/2012 | 56.6 | NA | NA | NA | 7 000 |
| P18-1 | Chronic | 12/15/2008 | 41.47 | 9.40 | 38 | 22 | 3 180 |
| P18-2 | Chronic | 1/6/2011 | 34.23 | 9.10 | 46 | 10 | 2 610 |
| P19-1 | Chronic | 3/13/2008 | 63.07 | 18.10 | 65 | 9 | 3 590 |
| P19-2 | Chronic | 6/16/2010 | 73.27 | 13.10 | 54 | 12 | 5 390 |
| P20-1 | Chronic | 9/16/2009 | 83.81 | 50.32 | 39.5 | 40.5 | 14 200 |
| P20-2 | Acute | 9/21/2011 | 51.42 | 52.71 | 0.4 | 97.8 | 300 |
| ID . | Status* . | Time point (month/day/year) . | Proviral load (%) . | WBC, ×109/L . | Lymphocyte count (%) . | Abnormal lymphocyte (flower cell) count (%) . | Soluble interleukin-2 receptor, U/mL . |
|---|---|---|---|---|---|---|---|
| P1-1 | Asymptomatic carrier | 1/8/2008 | 1.1 | 6.00 | 37 | 3 | 307 |
| P1-2 | Asymptomatic carrier | 4/17/2013 | 1.24 | 5.80 | 12 | 5 | 4 790 |
| P2-1 | Asymptomatic carrier | 6/25/2010 | 5.24 | 3.40 | 48 | 0.5 | 232 |
| P2-2 | Asymptomatic carrier | 3/26/2013 | 1.23 | 3.69 | 40 | 2.3 | 435 |
| P3-1 | Asymptomatic carrier | 12/14/2007 | 1.15 | 5.18 | 32.5 | 2 | 435 |
| P3-2 | Asymptomatic carrier | 1/28/2010 | 3.68 | 5.56 | 37 | 0 | 373 |
| P4-1 | Asymptomatic carrier | 10/21/2009 | 3.52 | 9.40 | 29 | 1 | 504 |
| P4-2 | Asymptomatic carrier | 6/24/2013 | 8.73 | 7.40 | 22 | 0 | 291 |
| P5-1 | Asymptomatic carrier | 12/1/2011 | 7.16 | 6.48 | 34.5 | 4.5 | 453 |
| P5-2 | Asymptomatic carrier | 12/10/2013 | 12.76 | 5.37 | 36 | 2.3 | 292 |
| P6-1 | Asymptomatic carrier | 9/14/2007 | 11.82 | 6.32 | 35.5 | 2.5 | 325 |
| P6-2 | Smoldering | 10/11/2011 | 11.51 | 5.88 | 36 | 7 | 355 |
| P6-3 | Smoldering | 4/1/2014 | 15.41 | 5.66 | 33.5 | 7 | 300 |
| P6-4 | Smoldering | 3/30/2015 | 23.45 | 6.06 | 37.5 | 6.5 | 268 |
| P7-1 | Asymptomatic carrier | 9/7/2005 | 18.22 | 8.48 | 41 | 0 | 595 |
| P7-2 | Asymptomatic carrier | 9/6/2007 | 11.66 | 9.48 | 37.5 | 3.5 | 544 |
| P7-3 | Chronic | 5/2/2011 | 56.79 | 10.14 | 14.5 | 52 | 6 800 |
| P7-4 | Acute | 11/21/2011 | 98.31 | 27.23 | 8.4 | 65.4 | 10 700 |
| P8-1 | Asymptomatic carrier | 4/13/2011 | 13.41 | 4.30 | 39 | 3 | 626 |
| P8-2 | Smoldering | 6/20/2012 | 17.54 | 5.00 | 33 | 13 | 467 |
| P8-3 | Smoldering | 5/28/2014 | 45.27 | NA | NA | NA | NA |
| P8-4 | Chronic | 8/19/2015 | 41.02 | NA | NA | NA | NA |
| P9-1 | Asymptomatic carrier | 2/27/2012 | 19.82 | NA | NA | NA | NA |
| P9-2 | Smoldering | 5/1/2014 | 21.78 | NA | NA | NA | NA |
| P9-3 | Smoldering | 5/1/2015 | 43.85 | NA | NA | NA | NA |
| P10-1 | Smoldering | 9/6/2011 | 20.46 | 5.10 | 37 | 6 | 523 |
| P10-2 | Smoldering | 5/12/2015 | 40.67 | 6.20 | 34 | 6 | 643 |
| P11-1 | Smoldering | 10/4/2012 | 36.63 | 6.04 | 28.5 | 24.5 | 1 700 |
| P11-2 | Chronic | 7/18/2013 | 37.32 | 6.92 | 13.5 | 51 | 7 000 |
| P12-1 | Smoldering | 7/27/2009 | 23.56 | 5.00 | 23 | 18 | 992 |
| P12-2 | Chronic | 6/1/2013 | 65.78 | NA | NA | NA | NA |
| P13-1 | Smoldering | 9/29/2010 | 31.1 | 10.20 | 21 | 15 | 1 320 |
| P13-2 | Chronic | 7/26/2012 | 32.15 | 9.40 | 51 | 14 | 1 780 |
| P14-1 | Smoldering | 11/10/2009 | 55.12 | 14.00 | 7 | 52 | 1 940 |
| P14-2 | Chronic | 5/23/2013 | 54.39 | 11.80 | 16 | 35 | 2 260 |
| P15-1 | Smoldering | 5/11/2007 | 16.9 | 9.80 | 44 | 0 | 833 |
| P15-2 | Chronic | 11/10/2010 | 28.53 | 12.70 | 52 | 14 | 823 |
| P16-1 | Smoldering | 10/17/2002 | 44.80 | 7.40 | 15 | 32 | 1 250 |
| P16-2 | Acute | 5/20/2004 | 105.98 | 12.80 | 4 | 76 | 12 800 |
| P17-1 | Chronic | 12/15/2010 | 59.3 | NA | NA | NA | 1 700 |
| P17-2 | Chronic | 11/26/2012 | 56.6 | NA | NA | NA | 7 000 |
| P18-1 | Chronic | 12/15/2008 | 41.47 | 9.40 | 38 | 22 | 3 180 |
| P18-2 | Chronic | 1/6/2011 | 34.23 | 9.10 | 46 | 10 | 2 610 |
| P19-1 | Chronic | 3/13/2008 | 63.07 | 18.10 | 65 | 9 | 3 590 |
| P19-2 | Chronic | 6/16/2010 | 73.27 | 13.10 | 54 | 12 | 5 390 |
| P20-1 | Chronic | 9/16/2009 | 83.81 | 50.32 | 39.5 | 40.5 | 14 200 |
| P20-2 | Acute | 9/21/2011 | 51.42 | 52.71 | 0.4 | 97.8 | 300 |
ID, identifier; NA, not available; WBC, white blood cell count.
Clinical diagnosis of each sample, based on Shimoyama criteria.